BioWorld

July 27, 2005

View Archived Issues

Invitrogen Adding New Products Via $130M BioSource Purchase

In order to grow in the area of proteomics, Invitrogen Corp. signed a definitive agreement to acquire BioSource International Inc. for about $130 million in cash. (BioWorld Today) Read More

Genitope's Stock Tumbles As MyVax's Phase III Continues

Read More

Kirin Buys Transgenic Cow Firm Hematech For $45M

Read More

Valeant Prepares For Phase III Retigabine Studies In Epilepsy

Read More

Correction

Read More

Other News To Note

Read More